Literature DB >> 19466907

Influence of jet nebulization and oxygen delivery on the fraction of inspired oxygen: an experimental model.

Vincent Caille1, Stephan Ehrmann, Eric Boissinot, Dominique Perrotin, Patrice Diot, Pierre-François Dequin.   

Abstract

BACKGROUND: The fraction of inspired oxygen (FiO(2)) during oxygen-driven jet nebulization is unknown. In the case of air-driven jet nebulization, oxygen is often added through a nasal device, and again, the FiO(2) is unknown. The aim of this experimental study was to measure FiO(2) during oxygen- and air-driven jet nebulization, oxygen being added through a nasal device, and to compare the values observed with those measured during standard oxygen therapy.
METHODS: An endotracheal tube was inserted into the distal tracheal extremity of a cadaveric head and neck specimen and connected to a pump, simulating different respiratory patterns. FiO(2) was measured using an electrochemical oxygen analyzer under different nebulization and oxygen delivery conditions. Variables were compared using canonical analysis and analysis of simple and multiple variance.
RESULTS: FiO(2) was significantly influenced by the mode of oxygen delivery (p = 0.001). The highest FiO(2) was observed when oxygen was delivered via a nasopharyngeal catheter associated with air-driven jet nebulization. For oxygen flow rates of 12 and 15 L/min, a nasal cannula combined with air-driven jet nebulization resulted in a similar FiO(2). The FiO(2) was significantly lower in the case of oxygen-driven jet nebulization. The FiO(2) decreased with increasing respiratory rate (p < 0.001) and tidal volume (p < 0.001).
CONCLUSIONS: Oxygen delivery through a nasal device during air-driven jet nebulization significantly increases the FiO(2), whereas oxygen-driven jet nebulization dramatically decreases FiO(2) compared with standard oxygen therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19466907     DOI: 10.1089/jamp.2008.0718

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  4 in total

Review 1.  Clinical experimentation with aerosol antibiotics: current and future methods of administration.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Konstantinos Porpodis; Dionysios Spyratos; Kosmas Tsakiridis; Haidong Huang; Qiang Li; J Francis Turner; Robert Browning; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2013-10-02       Impact factor: 4.162

Review 2.  Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d'Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies.

Authors:  Philippe Le Conte; Nicolas Terzi; Guillaume Mortamet; Fekri Abroug; Guillaume Carteaux; Céline Charasse; Anthony Chauvin; Xavier Combes; Stéphane Dauger; Alexandre Demoule; Thibaut Desmettre; Stephan Ehrmann; Bénédicte Gaillard-Le Roux; Valérie Hamel; Boris Jung; Sabrina Kepka; Erwan L'Her; Mikaël Martinez; Christophe Milési; Élise Morawiec; Mathieu Oberlin; Patrick Plaisance; Robin Pouyau; Chantal Raherison; Patrick Ray; Mathieu Schmidt; Arnaud W Thille; Jennifer Truchot; Guillaume Valdenaire; Julien Vaux; Damien Viglino; Guillaume Voiriot; Bénédicte Vrignaud; Sandrine Jean; Eric Mariotte; Pierre-Géraud Claret
Journal:  Ann Intensive Care       Date:  2019-10-10       Impact factor: 6.925

3.  Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis.

Authors:  Elena Fernández Fernández; Mary Joyce; Andrew O'Sullivan; Ronan MacLoughlin
Journal:  Antibiotics (Basel)       Date:  2021-04-21

4.  [Can mesh nebulizers improve prehospital aerosol therapy? An in vitro study on simulated prehospital emergency patients suffering from respiratory distress].

Authors:  M Otto; Y Kropp; L Kummer; M Thiel; C Tsagogiorgas
Journal:  Anaesthesiologie       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.